The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 119.00
Bid: 119.00
Ask: 120.00
Change: -0.50 (-0.42%)
Spread: 1.00 (0.84%)
Open: 119.00
High: 120.00
Low: 119.00
Prev. Close: 120.00
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

1 Mar 2024 07:00

RNS Number : 0468F
Litigation Capital Management Ltd
01 March 2024
 

1 March 2024

Litigation Capital Management Limited

("LIT", the "Company" or the "Group")

Transaction in Own Shares

 

The Company announces that Canaccord Genuity Limited ("Canaccord") has made the following purchases of ordinary shares of no par value in the capital of the Company ("Ordinary Shares"), on its behalf on the London Stock Exchange, pursuant to the Share Buyback Programme announced on 5 October 2023.

Date of purchase

29 February 2024

Number of Ordinary Shares purchased (aggregated volume):

33,000

Highest Price paid per Ordinary Share (p):

101

Lowest Price paid per Ordinary Share (p):

99.4

Volume Weighted Average Price paid per Ordinary Share (p):

100.07

Venue where Ordinary Shares are traded

London Stock Exchange (AIM)

Canaccord holds the repurchased shares on behalf of the Company. Following the purchase, the number of Ordinary Shares in issue and admitted to trading on AIM will be 117,776,749 excluding shares held by Canaccord (being the "Total Share Capital"). Canaccord on behalf of the Company will hold 1,423,583 ordinary shares, representing approximately 1.2087 per cent of the Total Share Capital.

 

This figure of 117,776,749 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The Company and Canaccord will make further announcements in due course following the completion of any further purchases pursuant to the Share Buyback Programme.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Canaccord on behalf of the Company.

Individual transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Trading venue

17,500

99.4

11:59:28

London Stock Exchange

10,000

101

14:25:34

London Stock Exchange

5,500

100.5

15:09:24

London Stock Exchange

 

Enquiries

 

Litigation Capital Management

c/o Tavistock

Patrick Moloney, Chief Executive Officer

Mary Gangemi, Chief Financial Officer

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam / Alex Orr

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

Tavistock (PR and IR)

Tel: 020 7920 3150

Tim Pearson

Katie Hopkins

lcm@tavistock.co.uk

 

NOTES TO EDITORS

Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its income from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management. Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDKLFLZLLFBBL
Date   Source Headline
13th Aug 20207:16 amRNSDisputes Finance Facility with Global Law Firm
10th Jul 20207:04 amRNSMarket Update
6th Jul 20204:40 pmRNSSecond Price Monitoring Extn
6th Jul 20204:35 pmRNSPrice Monitoring Extension
2nd Jul 202010:42 amRNSBoard Updates
26th May 20207:00 amRNSAustralian Regulation of Litigation Funders
22nd May 20204:41 pmRNSSecond Price Monitoring Extn
22nd May 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSConclusion of Joint Venture Arrangement
3rd Apr 20207:08 amRNSManagement Update and Corporate Reorganisation
24th Mar 20207:00 amRNSFinal closure of US$150 million fund
23rd Mar 20207:41 amRNSDirector/PDMR Shareholding
17th Mar 20207:00 amRNSHalf-year Report
10th Mar 20207:00 amRNSFirst close of a new US$150 million fund
13th Feb 20207:00 amRNSNotice of Results
6th Feb 202012:07 pmRNSSecond Price Monitoring Extn
6th Feb 202012:02 pmRNSPrice Monitoring Extension
20th Dec 20198:04 amRNSCase Investment Settlement Update
16th Dec 20194:41 pmRNSSecond Price Monitoring Extn
16th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Dec 201912:07 pmRNSSecond Price Monitoring Extn
11th Dec 201912:02 pmRNSPrice Monitoring Extension
10th Dec 20197:00 amRNSCapital Markets Event and Third-Party Fund Update
2nd Dec 20197:00 amRNSNotice of Dividend Currency Exchange Rate
21st Nov 20199:30 amRNSHolding(s) in Company
21st Nov 20198:25 amRNSResult of AGM
18th Nov 201912:23 pmRNS2019 Annual Report & Accounts
12th Nov 201912:07 pmRNSSecond Price Monitoring Extn
12th Nov 201912:02 pmRNSPrice Monitoring Extension
6th Nov 20197:00 amRNSAppointment of Joint Broker
1st Nov 201911:23 amRNSIncentive Awards
16th Oct 20198:00 amRNSNotice of Annual General Meeting
30th Sep 201912:00 pmRNSHolding(s) in Company
30th Sep 201912:00 pmRNSHolding(s) in Company
13th Sep 20193:01 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSFinal Results
2nd Sep 20197:30 amRNSNotice of Results
17th Jul 201910:42 amRNSHolding(s) in Company
28th Jun 201911:44 amRNSConditional Settlement of Litigation Project
13th Jun 20197:00 amRNSFunding of Corporate Portfolio Transaction
3rd Jun 20198:59 amRNSNotice of Dividend Currency Exchange Rate
28th May 20197:42 amRNSCourt Approval Settlement and Pipeline Update
8th Apr 201910:14 amRNSHolding(s) in Company
5th Apr 201912:18 pmRNSHolding(s) in Company
1st Apr 20199:00 amRNSTotal Voting Rights
28th Mar 20191:32 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSGlobal cooperation agreement with law firm
20th Mar 20199:56 amRNSSettlement in principle of litigation project
8th Mar 20197:00 amRNSJSOP Award
7th Mar 20195:08 pmRNSAppointment of Jonathan Moulds as Chairman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.